日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patient and public health perspectives to inform expansion of hepatitis B treatment guidelines

从患者和公共卫生角度出发,为扩大乙型肝炎治疗指南提供信息

Cohen, Chari; Tu, Thomas; Matthews, Philippa C; Wang, Su; Hicks, Jessica; El-Sayed, Manal H; Tavis, John E

Scientific and medical evidence informing expansion of hepatitis B treatment guidelines

为扩大乙型肝炎治疗指南提供科学和医学依据

Kennedy, Patrick T; Allweiss, Lena; Bertoletti, Antonio; Cornberg, Markus; Gehring, Adam J; Guidotti, Luca G; Kerth, Hélène A; Lemoine, Maud; Levrero, Massimo; Lim, Seng Gee; Tavis, John E; Testoni, Barbara; Tu, Thomas

Targeting HBV with RNA interference: Paths to cure

利用RNA干扰靶向乙肝病毒:治愈之路

Iannacone, Matteo; Beccaria, Cristian G; Allweiss, Lena; Lucifora, Julie; Tavis, John E; Gehring, Adam J; Dandri, Maura

Design, Synthesis, and Biological Evaluation of Highly Potent Boronic Acid (Boronate Ester)-Bearing Heteroaryldihydropyrimidine Derivatives as HBV Capsid Assembly Modulators

高效硼酸(硼酸酯)杂芳基二氢嘧啶衍生物作为乙型肝炎病毒衣壳组装调节剂的设计、合成和生物学评价

Jin, Yu; Sun, Yang; Zhao, Shujie; Wang, Shuo; Dou, Yutong; Wang, Kai; Li, Qilan; Tavis, John E; Wu, Zhuanchang; Zhan, Peng; Liu, Xinyong

Discovery of N-Hydroxypyridinedione-Based Inhibitors of HBV RNase H: Design, Synthesis, and Extended SAR Studies

基于N-羟基吡啶二酮的HBV RNase H抑制剂的发现:设计、合成和扩展构效关系研究

Chotzalli, Dea; Pardali, Vasiliki; Walden, Holly M; Perivolaris, Dimitrios; Moianos, Dimitrios; Makri, Maria; Drakopoulos, Antonios; Giannakopoulou, Erofili; Tajwar, Razia; Woodson, Molly E; Tavis, John E; Zoidis, Grigoris

Efficacy and in vitro pharmacological assessment of novel N-hydroxypyridinediones as hepatitis B virus ribonuclease H inhibitors

新型N-羟基吡啶二酮类化合物作为乙型肝炎病毒核糖核酸酶H抑制剂的疗效及体外药理学评价

Woodson, Molly E; Walden, Holly F; Mottaleb, M Abdul; Makri, Maria; Prifti, Georgia-Myrto; Moianos, Dimitrios; Pardali, Vasiliki; Zoidis, Grigoris; Tavis, John E

Correction for Woodson et al., "Efficacy and in vitro pharmacological assessment of novel N-hydroxypyridinediones as hepatitis B virus ribonuclease H inhibitors"

对 Woodson 等人的文章“新型 N-羟基吡啶二酮类化合物作为乙型肝炎病毒核糖核酸酶 H 抑制剂的功效和体外药理学评估”的更正

Woodson, Molly E; Walden, Holly F; Mottaleb, M Abdul; Makri, Maria; Prifti, Georgia-Myrto; Moianos, Dimitrios; Pardali, Vasiliki; Zoidis, Grigoris; Tavis, John E

N-Hydroxypiridinedione: A Privileged Heterocycle for Targeting the HBV RNase H

N-羟基吡啶二酮:一种靶向HBV RNase H的优势杂环化合物

Moianos, Dimitrios; Makri, Maria; Prifti, Georgia-Myrto; Chiotellis, Aristeidis; Pappas, Alexandros; Woodson, Molly E; Tajwar, Razia; Tavis, John E; Zoidis, Grigoris

Major open questions in the hepatitis B and D field - Proceedings of the inaugural International emerging hepatitis B and hepatitis D researchers workshop

乙肝和丁肝领域的主要未解问题——首届国际新兴乙肝和丁肝研究人员研讨会论文集

Tu, Thomas; Wettengel, Jochen; Xia, Yuchen; Testoni, Barbara; Littlejohn, Margaret; Le Bert, Nina; Ebert, Gregor; Verrier, Eloi R; Tavis, John E; Cohen, Chari

In vitro evaluation of tropolone absorption, metabolism, and clearance

体外评价托酚酮的吸收、代谢和清除率

Woodson, Molly E; Mottaleb, M Abdul; Murelli, Ryan P; Tavis, John E